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Summary
INTRODUCTION: There is a scarcity of studies on labour
outcomes with defibulation. This study assessed the out-
comes of labour with defibulation at delivery in women with
type III female genital mutilation/cutting (FGM/C) com-
pared to labour without defibulation.
METHODS: We identified and reviewed the records of
all Somali and Sudanese women who delivered at King
Abdulaziz University Hospital, Jeddah, Saudi Arabia, be-
tween January 2012 and December 2016. Labour out-
comes of women with type III FGM/C who delivered vagi-
nally with defibulation at delivery were compared to the
outcomes of women without type III FGM/C who delivered
vaginally without defibulation. Data extracted from the
records included demographics, registration status, and
labour outcomes.
RESULTS: During the study period, 1086 Somali and Su-
danese women delivered at our institution, with 42% deliv-
ering by caesarean section. Among the 631 women with
vaginal delivery, 27% had type III FGM/C and delivered
with defibulation while 73% did not have type III FGM/C
and delivered without defibulation. Demographic and clin-
ical factors were similar between the two groups who de-
livered vaginally. The outcomes of labour with defibulation
at delivery in women with type III FGM/C were not differ-
ent from women without defibulation, except in regards to
instrumental delivery and maternal blood loss. There were
also no statistically significant differences between the two
groups in neonatal outcomes.
CONCLUSIONS: Defibulation at delivery is an effective
minor surgical procedure that should be in the armamen-
tarium of the healthcare providers managing women with
type III FGM/C.
Keywords: labour, outcomes, defibulation at delivery
Introduction
Female genital mutilation/cutting (FGM/C) is defined by
the World Health Organization (WHO) as all non-medical
procedures that involve partial or total removal of the ex-
ternal female genitalia, or other injury to the external fe-
male genital organs [1]. The WHO classifies FGM/C into
four types: type I, excision of the prepuce with or without
excision of a portion of the clitoris; type II, excision of
any portion of the labia minora and/or clitoris with or with-
out excision of some part or all of the labia majora; type
III, narrowing of the vaginal orifice (infibulation) with or
without excision of any portion of the clitoris and apposi-
tion of the labia minora or labia majora; type IV, all other
harmful procedures to the female genitalia for non-medical
purposes, such as pricking, piercing, incising, scraping and
cauterising the genital area [1]. It is practiced most com-
monly in the western, eastern, and north-eastern regions of
Africa, as well as in a few Middle Eastern countries such
as Iraq and Yemen [2]. FGM/C is also practiced among mi-
grants from these areas, which highlights the global scale
of this issue [3]. Although the exact number of girls and
women who are subjected to the practice of FGM/C world-
wide is unknown, the United Nations International Chil-
dren's Emergency Fund estimates that there are around
200 million girls and women alive today who have under-
gone FGM/C [2]. There are no known health benefits to
the traditional practice of FGM/C. On the contrary, it re-
sults in well-documented short- and long-term detrimental
health sequelae [4, 5]. In particular, although the precise
size of the increased risk is uncertain, systematic reviews
have documented that women who have undergone FGM/
C are significantly more likely than women without FGM/
C to suffer adverse obstetric outcomes, such as prolonged
labour, difficult labour, haemorrhage and blood loss [5, 6].
One of the potential obstetrical challenges related to this
practice is the need for defibulation to allow a safe vagi-
nal delivery. Defibulation is a minor surgical procedure
to re-open the vaginal introitus by dividing the scar tis-
sue sealing the vaginal introitus in type III FGM/C [7].
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It can be performed before pregnancy, antenatally, in the
first stage of labour, and at the time of vaginal delivery
[7]. There is little familiarity with this procedure in de-
veloped countries and caregivers may not be prepared to
treat women with infibulation, especially in emergency sit-
uations, which in turn may lead to rupture of the infibula-
tion scar [8, 9]. The WHO guideline on the management
of complications from FGM/C recommends undertaking
defibulation in the antepartum or intrapartum period [1].
However, the guideline is based on a systematic review
of only four case-control studies [10]. Another systematic
review described the defibulation results of eight studies,
which reported more than 30 different obstetric outcomes
[11]. Yet, this review also called for additional research on
the benefits and harms of defibulation for women who live
with type III FGM/C, in particular from developing coun-
tries where FGM/C is commonly practiced, so that health
care providers can draw firmer conclusions on the effec-
tiveness of this care intervention. To this end, the objec-
tive of our study was to assess the outcomes of labour with
defibulation at delivery in a non-inferiority comparison of
women with type III FGM/C compared with women with-
out defibulation. Given that defibulation prevents obstruc-
tion of labour and rupture of the scar, we hypothesised that
there would be no statistically significant differences in the
outcomes between the two groups of women.
Materials and methods
We conducted a retrospective, chart review study with ethi-
cal approval from the Unit of Biomedical Ethics at the Fac-
ulty of Medicine at King Abdulaziz University (Number
423-16). We identified and reviewed the medical records
of all Somali and Sudanese women who delivered at King
Abdulaziz University Hospital, Jeddah, Saudi Arabia be-
tween January 2012 and December 2016. We selected im-
migrant Somali and Sudanese women because the preva-
lence of FGM/C, including type III, is particularly high
in these countries [2] and they make up a substantial pro-
portion of the immigrant female patients at our institution.
We identified Somali and Sudanese women who were ad-
mitted for delivery from the labour ward records. From
the records, we extracted data on demographic and clinical
characteristics, medical and obstetric history, as well as
pregnancy outcomes, including labour characteristics, de-
livery outcomes, and postpartum complications (e.g.,
blood loss at delivery, which is measured visually). The
hospital discharge notes gave information on neonatal out-
comes, including gestational age at delivery, birth weight,
and major morbidities. If a woman had more than one de-
livery during the study period, we used data only from her
first delivery.
The outcomes of the labour of women who delivered vagi-
nally with defibulation at delivery were compared to the
outcomes of women who delivered vaginally without de-
fibulation (variables stated above and shown in tables 2
and 3 below). The women with and without defibulation
were from the same nationalities where FGM/C is near
universal [2], and they had deliveries in the same period.
Therefore, although women’s FGM/C status was only
recorded when it was type III, we expect that the other
women had type I or II FGM/C.
King Abdulaziz University Hospital is a free tertiary re-
ferral government teaching hospital. Saudi and all eligible
immigrant pregnant women from different socio-economic
backgrounds are routinely followed in the antenatal clinics
(registered). Immigrant non-eligible pregnant women who
are not registered during pregnancy may present to the
emergency department in established labour without any
prior antenatal care (unregistered). The hospital’s policy is
to accept and admit them. As a routine, the presence of
type III FGM/C is documented during the initial vaginal
examination when women present in labour. The examina-
tion is followed by counselling and approval of the proce-
dure to be adopted. Concerning defibulation, vaginal de-
livery for women with type III FGM/C is achieved by
performing defibulation at the time of crowning of the fetal
head (video 1) followed by medio-lateral episiotomy if re-
quired, as described elsewhere [12]. Vaginal delivery for
women without FGM/C or with other types of FGM/C is
achieved without defibulation. Medio-lateral episiotomy is
done when necessary. Delivery is conducted by in-house
staff, usually residents and senior residents under the care
of the attending on call. Intrapartum continuous fetal heart
monitoring is performed for almost all women. Intramus-
cular, intravenous, or epidural analgesia is given for pain
relief during labour.
Data were analysed using the Statistical Package for the
Social Sciences (SPSS Inc., Chicago, IL), version 23. We
calculated frequencies and means ± standard deviation
(SD) and analysed differences between groups using Stu-
dent’s t-test for continuous variables and the chi-square test
for categorical variables. A p-value <0.05 was considered
statistically significant.
Results
During the study period, 1086 Somali and Sudanese
women delivered at our hospital, with 455 (42%) deliv-
ering by caesarean section. The caesarean sections were
done for obstetric indications, with none done for the in-
dication of FGM/C. Among the 631 women with vaginal
delivery, 27% had type III FGM/C and delivered with de-
fibulation while 73% did not have type III FGM/C and
delivered without defibulation. There was no spontaneous
rupture of the infibulation scar before the intended defibu-
lation at the time of crowning of the fetal head. Defibula-
tion was successfully and easily performed with no woman
experiencing any intraoperative complication. As shown in
table 1, demographic and clinical factors were similar be-
tween the women who delivered vaginally with and with-
out defibulation. Table 2 shows that there were no statisti-
cally significant differences between the two groups in the
onset of labour, duration of the stage of labour, meconi-
um-stained liquor, episiotomy, vaginal tears, the need for
blood transfusion, or maternal duration of hospital stay.
However, there was a statistically significant difference be-
tween the groups with regard to instrumental delivery and
blood loss. There were more instrumental deliveries (9.1 vs
1.2%, p <0.001) and greater blood loss (293.6 vs 248.7 ml,
Video 1: Defibulation at delivery. You will find the video file online at https://smw.ch/article/doi/smw.2020.20326
Original article Swiss Med Wkly. 2020;150:w20326
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 2 of 5
p = 0.040) in women who delivered without defibulation.
There were no statistically significant differences between
the two treatment groups in neonatal outcomes (table 3).
Discussion
In this comparison study, we hypothesised that the out-
comes of labour with defibulation at delivery in women
with type III FGM/C would be no different from women
without defibulation. With the exception of two outcomes,
instrumental delivery and maternal blood loss, the results
were consistent with our hypothesis. Furthermore, no
woman experienced any intraoperative complication. This
suggests that defibulation at delivery is a safe procedure
and that it reduces the risk of obstetric complications for
women with type III FGM/C, as suggested in the system-
atic review by Berg et al. [11] The fact that the Somali and
Sudanese women who delivered with defibulation had sig-
nificantly fewer instrumental deliveries and less blood loss
than the women who delivered without defibulation sug-
gests that defibulation created a more favorable labour. It
is possible that this care intervention redressed obstetric






Age (years) 30.5 ± 7.1 29.7 ± 6.5 0.186
Body mass index (kg/m2) 27.8 ± 5.3 27.8 ± 5.0 0.879
Nationality 0.166
– Somali 107 (62.9%) 317 (68.8%)
– Sudanese 63 (37.1%) 144 (31.2%)
Booking status 0.602
– Registered 26 (15.3%) 63 (13.7%)
– Unregistered 144 (84.7%) 398 (86.3%)
Gravidity 3.5 ± 2.5 3.4 ± 2.4 0.414
Parity 2.2 ± 2.3 2.1 ± 2.2 0.825
Gestational age (weeks) 39.0 ± 2.5 39.1 ± 2.6 0.590
Hepatitis 3 (1.8) 11 (2.4) 0.769
Data are presented as mean ± standard deviation or n (%). A p-value <0.05 is considered statistically significant.






Onset of labour 0.233
– Spontaneous 166 (97.6%) 456 (98.9%)
– Induced 4 (2.4%) 5 (1.1%)
Instrumental delivery <0.001
– Ventouse 2 (1.2%) 42 (9.1%)
– Forceps 0 4 (0.9%)
First stage (min) 185.9 ± 165.0 183.73 ± 82.8 0.772
Second stage (min) 14.2 ± 7.8 14.7 ± 7.8 0.470
Third stage (min) 6.3 ± 2.2 6.1 ± 2.1 0.532
Meconium-stained liquor 35 (20.6%) 84 (18.2%) 0.500
Episiotomy 68 (40%) 166 (36%) 0.357
Vaginal tears
– First degree 54 (31.8%) 125 (27.1%) 0.250
– Second degree 20 (11.8%) 39 (8.55) 0.209
– Third degree 4 (2.4%) 5 (1.1%) 0.260
– Fourth degree 0 0 0.250
Blood loss (ml) 248.7 ± 157.1 293.6 ± 268.5 0.040
Blood transfusion 9 (5.3%) 41 (8.9%) 0.142
Hospital stay (days) 2.1 ± 1.7 2.4 ± 4.7 0.373
Data are presented as mean ± standard deviation or n (%). A p-value <0.05 is considered statistically significant.






Apgar score <7 at 5 minutes 3 (1.8) 18 (3.9) 0.218
Need for resuscitation 10 (6.0) 49 (10.6) 0.063
Respiratory distress syndrome 1 (0.6) 8 (1.7) 0.455
Neonatal intensive care unit admission 13 (7.6) 50 (10.8) 0.224
Hypoxic ischaemic encephalopathy 0 9 (2) 0.122
Birth weight (g) 3200.9 ± 582.7 3190.6 ± 592.7 0.855
Data are presented as mean ± standard deviation or n (%). A p-value <0.05 is considered statistically significant.
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problems caused by inelastic scar tissue from FGM/C,
which is the most plausible mechanistic pathway of the in-
creased obstetric harms in women with type III FGM/C.
In the developing world, prolonged second stage of labour,
extensive perineal tears, damage to the adjacent structures
like the urethra, the bladder, and the rectum, vesicovaginal
and rectovaginal fistulae, birth asphyxia, and stillbirth can
follow vaginal delivery without defibulation [7]. In con-
trast, studies from the developed world have shown that a
high standard of antenatal care, defibulation, skilled birth
attendants, and professional surveillance of labour can
minimise the adverse obstetrics outcomes [13, 14].
In 2016, the WHO strongly recommended defibulation for
the prevention of obstetric complications in women with
type III FGM/C [1]. The WHO evidence base used for the
recommendation was a systemic review and meta-analy-
sis on defibulation published in 2017 [8]. It included four
case-controlled studies: two from the United Kingdom [15,
16] and our previous two studies [12, 17]. The two studies
from the United Kingdom found better obstetric outcomes
among women who underwent defibulation during labour,
compared with women who remained infibulated. The pol-
icy in our hospital, as well as the prevailing standard in
Saudi Arabia, is to do defibulation in labour [18]. Intra-
partum defibulation is also the “usual practice” in countries
where FGM/C is prevalent [7]. Importantly, it is the pre-
ferred option by women because most women find that it
facilitates an easier birth and it avoids being cut twice, an-
tenatally and in labour for episiotomy [19].
We acknowledge that our study comes with strengths and
limitations. Strengths include the large sample size and
similarity between the two groups. However, the study
is retrospective, and while the clinical records included
whether the women had type III FGM/C, we do not know
the percentages of women who had other types of FGM/C
who subsequently had no defibulation. Likely, most if not
all women had type I or II FGM/C and in the unlikely event
they did not, that would only strengthen our results con-
cerning favourable effects of defibulation in women with
type III FGM/C. The ideal control group is women with
type III FGM/C who deliver without defibulation. In our
opinion, given the known benefits of defibulation, it would
be unethical to allow women with type III FGM/C to deliv-
er vaginally without defibulation. Such groups of women
do not exist in our practice. While outside the scope of our
study, we note that the unexpected high rate of caesarean
sections deserves attention and should be examined in fu-
ture studies.
Conclusion
Defibulation at delivery is an effective minor surgical pro-
cedure that should be in the armamentarium of the health-
care providers managing women with type III FGM/C.
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